Maria Sainz was appointed President & CEO of AEGEA Medical in May 2018. AEGEA, and its FDA-approved Mara™ Water Vapor Ablation System for endometrial ablation, were recently acquired by CooperSurgical.

She has over 25 years’ experience in commercial and leadership positions in the medtech industry. Maria has served as the President & CEO of Cardiokinetix, a medical device company pioneering a catheter-based treatment for heart failure. Prior to that, Maria was the President & CEO of Concentric Medical, Inc., a developer of minimally invasive products for the treatment of acute ischemic stroke which was acquired in 2011 by Stryker Corporation. Maria began her medtech career at Guidant Corporation where she held positions of increasing responsibility in Europe and the US. At the time of the acquisition of Guidant by Boston Scientific, Maria served as President of the Cardiac Surgery division of Guidant Corporation. Maria has been intimately involved in several major medtech product launches such as coronary stents or cardiac resynchronization therapy devices. Maria also serves as a Director of several public and private medical company boards. She received a M.A in Languages from the University Complutense in Madrid, Spain and a Masters in International Management from the American Graduate School of International Management.